Vi bruger cookies til statistik som en del af vores arbejde for at lave en god hjemmeside. Medmindre du siger "nej tak til cookies", antager vi, at du accepterer vores cookie-politik. For mere information, se vores "cookie-politik".

Du kan også klikke "ja tak til cookies" for at  acceptere vores cookie-politik

DATA PRESENTATION

Biological treatment in Danish dermatology

DATABASE

Primary variables


Biological treatment

Psoriasis

Side effects


 

List of variables not avaliable for download

Introduction

Biological Treatment in Danish Dermatology (DERMBIO) is a nationwide database
which contains data relating to all patients with psoriasis in biological treatment. The purpose of DERMBIO is quality assurance and developing the quality of biological treatment for psoriasis.

Data is reported from the all the country's hospital dermatology departments (Gentofte, Bispebjerg, Roskilde, Odense and Aarhus), and Danish dermatology practice for patients being treated for psoriasis. Data is gathered by way of a web-based user interface where the doctors or nurses who are dealing with the patient can enter relevant data.

DERMBIO has been operating since 2007 and is an initiative of the Danish Dermatology Society (DDS).

More details

Abbreviation
DERMBIO
Type
Nationwide clinical quality database
Purpose
Clinical quality

Collection Period

Collection Period
Coverage
Nationwide
Population
The population comprises all patients receiving biological treatment for psoriasis. Currently about 2250 patients are in the database, 1650 of whom are in ACTIVE biological treatment
Database Categories

Application requirements

The Regional Clinical Quality Databases

Data about clinical quality are collected with the purpose of monitoring and raising the quality of patient treatment in the Danish health-care system. These data can, as well as all other public registers, be made accessible for research projects based on systematic protocols and approved according to the relevant legislations.

Applying for access to data from a regional clinical database requires a list of demands to be obtained. A project description should be attached containing a description of the project explaining the rationale, purpose, methods, budget, publication plan etc.

Furthermore, The Danish Data Protection Agency must approve the project.

Application process

  • Application for data access is sent to the board of the database
  • After approval the application is forwarded to the contact person of the database
  • The contact person controls the application
  • If the application is complete the applicant must accept the terms of extradition of data (a written acceptance is sent via e-mail to the contact person)
  • The application is sent to data manager
  • Approval and extradition of data
  • within 30 days after data delivery the applicant must control the data extraction and afterwards it should be deleted

 

Legislation

The Regional clinical quality databases subject to rules for treatment of personal data, that should secure high quality of patient treatment in Denmark. These legislations include The Act on Processing of Personal Data (Danish: Persondataloven) and The Danish Act of Health (Danish: Sundhedloven). These legislations ensure that data access is limited to relevant purposes.

Contact information

Data owner
The Capital Region of Denmark
Contact data owner
Regionsgården 
Kongens vænge 2
3400 Hillerød
Website - data owner
bit.ly/regionh-english
Data administrator
The Danish Clinical Registries (RKKP)
Contact data administrator
Julie Tybjerg
T: 51 42 42 95
E: ANNTYB@rkkp.dk
Website - data administrator
bit.ly/biologisk-behandling-dermatologi-database
Website - data administrator
bit.ly/regionh-database-biologisk-dermatologi